跳至主要内容
临床试验/NCT01143233
NCT01143233已完成不适用

Suitability of an Infant Formula With Reduced Protein Content Based on a Partial Respectively an Extensive Proteinhydrolysate With and Without Pro- and Prebiotics for the Particular Nutritional Use by Infants.-Extension by 4 Year Follow-up

HiPP GmbH & Co. Vertrieb KG5 个研究点 分布在 3 个国家目标入组 503 人开始时间: 2010年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
503
试验地点
5
主要终点
average weight gain

研究概览

简要总结

The study is conducted to examine the suitability of partially respectively extensively hydrolyzed low protein infant formulae with and without pro- and prebiotics for healthy, term infants.

Primary hypothesis to be tested is: an infant formula based on a Protein hydrolysate with modified protein content is non inferior compared to a standard infant formula based on a Protein hyrolysate in respect to proper growth of healthy, term infants within the first four month of life.

4-year follow-up (without further Intervention) will focus on body composition and allergic predisposition.

详细描述

View Section Brief Summary

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
1 Day 至 27 Days(Child)
性别
All
接受健康志愿者
是

入选标准

  • •written informed consent (by parents, caregiver)
  • •Healthy term newborns (gestational age: ≥ 37 weeks)
  • •Birth weight between 2.500 - 4.500 g
  • •Age at enrolment: < 28 days of age
  • •Infant received no other formula since birth
  • •Parents / Caregivers are able to speak German

排除标准

  • •Severe acquired or congenital illness
  • •preterm infants (gestational age < 37 weeks)
  • •Birth weight lower than 2.500 g or higher than 4.500 g
  • •Feeding a cows milk based formula or any other formula prior to inclusion in this study
  • •Participation in any other clinical study intervention
  • •Regular intake of supplementary pre- and probiotics by the child and/or breastfeeding mother
  • •Mothers with diabetes mellitus or mothers suffered from gestational diabetes
  • •Founded assumption that it will not be possible for parents / caregivers to be compliant with the study protocol
  • •Breastfed infants: illness of the mother, that may have an influence on the gastrointestinal tract of the child
  • •Breastfed infants: mother receives or received antibiotics one week before inclusion in this study or during the first study phase

研究组 & 干预措施

control formula group

Active Comparator

infants are fed a commercial, hydrolysed formula during the first 4 month of life, according to protocol

干预措施: control formula (Other)

intervention formula 1 group

Experimental

infants are fed hydrolyzed infant formula with different protein content during the first 4 month of life, according to protocol

干预措施: intervention formula 1 (Other)

intervention formula 2 group

Experimental

infants are fed hydrolyzed infant formula with different protein content with pro- and prebiotics during the first 4 month of life, according to protocol

干预措施: intervention formula 2 (Other)

intervention formula 3 group

Experimental

infants are fed hydrolyzed instant formula with different protein content with pro- and prebiotics during the first 4 months of life, according to protocol

干预措施: intervention formula 3 (Other)

Reference group

No Intervention

infants are breast fed

结局指标

主要结局

average weight gain

时间窗: 4 months

The intervention is to assess average weight gain in the first 4 months of life.

次要结局

  • Anthropometric data at age of 4 years(4 years)
  • Body composition (Skin fold) at age of 4 years(4 years)
  • Body composition (fat mass, lean body mass) at age of 4 years(4 years)
  • allergic sensitization and symptoms(12 months)
  • Allergic predisposition at age of 4 years by measuring specific IgE in blood(4 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验